PC(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))

Term ID

CHEBI:88434

Synonyms

(2-{[(2R)-3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyloxy]-2-[(9Z)-hexadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium
1-Docosapentaenoyl-2-palmitoleoyl-sn-glycero-3-phosphocholine
GPCho(22:5/16:1)
GPCho(22:5n3/16:1n7)
GPCho(22:5w3/16:1w7)
GPCho(38:6)
Lecithin
PC aa C38:6
PC(22:5/16:1)
PC(22:5n3/16:1n7)
PC(22:5w3/16:1w7)
PC(38:6)
Phosphatidylcholine(22:5/16:1)
Phosphatidylcholine(22:5n3/16:1n7)
Phosphatidylcholine(22:5w3/16:1w7)
Phosphatidylcholine(38:6)

(all 16)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

is a type of: 1,2-diacyl-sn-glycero-3-phosphocholine

1,2-diacyl-sn-glycero-3-phosphocholine Show first 5 Terms

Phenotype

Phenotype resulting from PC(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))

Phenotype where environments contain PC(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))

Phenotype modified by environments containing PC(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))

Phenotype affecting PC(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))

Human Disease Model